| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/07/2007 | US20070128694 Compositions and methods relating to the daptomycin biosynthetic gene cluster |
| 06/07/2007 | US20070128672 Complementarity determining region (CDR); cancer, rheumatoid arthritis; immunology |
| 06/07/2007 | US20070128664 Secreted polypeptide species associated with cardiovascular disorders |
| 06/07/2007 | US20070128660 Detecting tripeptide glycyl-L-prolyl-L-glutamic acid (gly-pro-glu; GPE antibodies derivatized with keyhole limpet hemocyanin, diethyl carbodiimide, 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate, or sulfosuccinimidyl 4-(N-maleimidomethyl) cyclohexane-1-carboxylate |
| 06/07/2007 | US20070128619 Human FGF-21 gene and gene expression products |
| 06/07/2007 | US20070128616 Aggrecanase molecules |
| 06/07/2007 | US20070128601 As a target for drug development against Chagas' disease; TcPRAC genes in T. cruzi encode functional intracellular or secreted versions of the enzyme exhibiting distinct kinetic properties that may be relevant for their relative catalytic efficiency |
| 06/07/2007 | US20070128595 Novel polynucleotide and polypeptide sequences and uses thereof |
| 06/07/2007 | US20070128591 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 06/07/2007 | US20070128259 AL-2 neurotrophic factor |
| 06/07/2007 | US20070128224 nucleic acid molecules derived from its genome, the proteins and peptides encoded by the nucleic acid molecules, for use in medical diagnosis and/or as vaccines |
| 06/07/2007 | US20070128221 An immunoassay device comprising a solid substrate having attached a polypeptide consisting of SEQ ID NO:3; new antigenic regions of hepatitis C virus referred to as HCV-3 and HCV-4 identified and sequenced to providemore complete blood screening and genotyping; immunoassays; antibodies; vaccines |
| 06/07/2007 | US20070128219 Molecular antigen arrays |
| 06/07/2007 | US20070128218 Diagnosis and treatment of hepatic disorders |
| 06/07/2007 | US20070128211 Surface proteins of Streptococcus pyogenes |
| 06/07/2007 | US20070128210 Surface proteins of Streptococcus pyogenes |
| 06/07/2007 | US20070128204 Methods and compositions for inducing apoptosis in cancer cells |
| 06/07/2007 | US20070128203 Anti-integrin antibodies, compositions, methods and uses |
| 06/07/2007 | US20070128202 inhibiting growth of cancerous cells using an antibody (mPA7) which binds to antigen CD46 which is present on a variety of human cancers from ovary, breast, lung, prostate, colon, kidney, and pancreas |
| 06/07/2007 | US20070128200 Thromboembolic disease, ischemic disease, venous thromboembolism, arterial or venous thrombosis, pulmonary embolism, restenosis, diabetic angiopathy and allograft atherosclerosis; peptides from the receptor binding region of human Growth Arrest Specific Gene 6 (Gas6) and antibodies |
| 06/07/2007 | US20070128198 Compositions comprising antibodies to human fgl2 |
| 06/07/2007 | US20070128197 Monoclonal antibody or an antigen-binding fragment thereof which binds to human VEGF-B (vascular endothelial growth factor) produced by hybridoma; neovascularization diseases; antitumor, anticarcinogenic, antiinflammatory, and antimetastasis agents; rheumatoid arthritis; angiogenesis inhibitors |
| 06/07/2007 | US20070128196 Methods and compositions for inhibiting angiogenesis |
| 06/07/2007 | US20070128195 Interleukins; Antigen binding fragment that binds to polypeptide of given sequence; immunogenic |
| 06/07/2007 | US20070128194 monoclonal antibody specific for human NDRG 2 (N-myc downstream regulated gene 2) protein; used to investigate and treat intractable diseases and cancers using the dendritic cell |
| 06/07/2007 | US20070128192 Human antibody molecules for il-13 |
| 06/07/2007 | US20070128191 Polyclonal antibodies, preparation method thereof and use of same |
| 06/07/2007 | US20070128190 Anti-alpha2 integrin antibodies and their uses |
| 06/07/2007 | US20070128189 Monoclonal antibodies as immunosuppressants, cytokine antagonists; antiinflammatory agents; cytokine suppressive antiinflammatory drug; biodrugs |
| 06/07/2007 | US20070128188 For stimulating release of tumor necrosis factor and/or cellular prolifefration/differentiation of chondrocytes by contacting blood w/polypeptide; diagnosis cancer |
| 06/07/2007 | US20070128187 modulating lipid levels and/or bone mass; diagnosis of abnormal lipid levels and bone mass disorders, such as osteoporosis; bone disorders; Paget's disease |
| 06/07/2007 | US20070128186 Proliferative glomerulonephritis-related gene |
| 06/07/2007 | US20070128185 Identification of unique binding interactions between certain antibodies and the human b7.1 and b7.2 co-stimulatory antigens |
| 06/07/2007 | US20070128184 Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists and immunotoxins |
| 06/07/2007 | US20070128157 Tumour suppressor protein |
| 06/07/2007 | US20070128115 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 06/07/2007 | US20070128112 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil. |
| 06/07/2007 | US20070128111 Immunoglobulin for use in treatment and prevention of immunological and cancer disorders; immunotherapy; antibodies with modified hinge cysteine residues |
| 06/07/2007 | US20070125418 Electrode, method of making same, photoelectric transfer element, method of manufacturing same, electronic device and method of manufacturing same |
| 06/07/2007 | CA2637472A1 Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins |
| 06/07/2007 | CA2632866A1 Noncompetitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 06/07/2007 | CA2632094A1 Carbonic anhydrase ix (g250) antibodies and methods of use thereof |
| 06/07/2007 | CA2631397A1 Peptide inhibitors of abl kinases |
| 06/07/2007 | CA2631292A1 Derivatised wt1 cancer antigen peptides and their use |
| 06/07/2007 | CA2631222A1 Vascular aging-predicting factor and utilization of the same |
| 06/07/2007 | CA2631195A1 Monoclonal antibodies against amyloid beta protein and uses thereof |
| 06/07/2007 | CA2630648A1 Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus (prrsv) and uses thereof |
| 06/07/2007 | CA2629850A1 Competitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 06/07/2007 | CA2628703A1 Anti-a.beta. globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies |
| 06/07/2007 | CA2619784A1 Methods of producing stable b-lymphocytes |
| 06/06/2007 | EP1792995A2 Chlamydia secretory locus orf and uses thereof |
| 06/06/2007 | EP1792992A1 Antigenic protein originating in Malassezia |
| 06/06/2007 | EP1792991A1 Human CTLA-4 antibodies and their uses |
| 06/06/2007 | EP1792989A1 13 Transmembrane protein expressed in prostate cancer |
| 06/06/2007 | EP1792988A2 Compounds and methods for therapy and diagnosis of lung cancer |
| 06/06/2007 | EP1792987A1 Method of producing glycoprotein composition |
| 06/06/2007 | EP1792981A1 Microginin producing proteins and nucleic acids encoding a microginin gene cluster as well as methods for creating microginins |
| 06/06/2007 | EP1792913A1 Novel secreted and membrane-associated proteins and uses therefor |
| 06/06/2007 | EP1792912A2 Novel proteins and nucleic acids encoding same |
| 06/06/2007 | EP1792625A1 Use of a phosphatidylserine/polypeptide conjugate for inducing autoimmunity in the treatment of cancers |
| 06/06/2007 | EP1792185A2 Lanthanide-based substrates and methods for determining clostridial toxin activity |
| 06/06/2007 | EP1791969A2 A method of treating cancer |
| 06/06/2007 | EP1791869A2 Anti-ox40l antibodies |
| 06/06/2007 | EP1791868A2 Antibodies binding to receptors kir2dl1, -2, 3 but not kir2ds4 and their therapeutic use |
| 06/06/2007 | EP1791867A2 Binding member towards pneumolysin |
| 06/06/2007 | EP1791866A2 Binding domain fusion proteins |
| 06/06/2007 | EP1791864A2 Methods of using death receptor ligands and cd20 antibodies |
| 06/06/2007 | EP1791563A2 Anti-cd154 antibodies |
| 06/06/2007 | EP1581644B1 Purification of polypeptides |
| 06/06/2007 | EP1476548B1 Process of cell electrofusion |
| 06/06/2007 | EP1402034B1 Identification of ses-1 and the uses of the same |
| 06/06/2007 | EP1354046B1 Regulation of expression of eer-7, a member of the lysyl oxidase gene family, by estrogen receptors |
| 06/06/2007 | EP1330651A4 Evaluating binding affinities by force stratification and force planning |
| 06/06/2007 | EP1181056B1 Lim mineralization protein splice variants |
| 06/06/2007 | EP1009826B1 Erbb4 receptor-specific neuregulin, related ligands and uses thereof |
| 06/06/2007 | EP0939824B1 Reagents and methods useful for detecting diseases of the breast |
| 06/06/2007 | EP0683234B2 Antibody against beta-amyloid or their derivative and use thereof |
| 06/06/2007 | CN1977043A Natural IgM antibodies and inhibitors thereof |
| 06/06/2007 | CN1976951A Anti-EpCAM immunoglobulins |
| 06/06/2007 | CN1976950A Anti-CD38 human antibodies and uses therefor. |
| 06/06/2007 | CN1976721A Method to reduce hepatotoxicity of FAS-mediated apoptosis-inducing agents |
| 06/06/2007 | CN1976720A Compositions and methods for treatment of severe acute respiratory syndrome (SARS) |
| 06/06/2007 | CN1974600A Flumequine resisting monoclonal antibody and its prepn process and application |
| 06/06/2007 | CN1320125C Preparation method of monoclonal antibody and application thereof |
| 06/06/2007 | CN1320114C Variable region gene in heavy chain and light chain of anti Pgp monoclone antibody and its application |
| 06/06/2007 | CN1320104C Bacterial strain for preparing high efficiency capsule glycoprotein immunomodulator, screening and application thereof |
| 06/06/2007 | CN1319991C Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides |
| 06/06/2007 | CN1319988C High affinity immune globulin binding molecule and method for preparation |
| 06/06/2007 | CN1319987C Gamma-secretase inhibitors |
| 06/05/2007 | US7227053 transformed in yeast; renders heterologeous organism tolerant to osmotic stress |
| 06/05/2007 | US7227011 Nucleic acid vaccines for prevention of flavivirus infection |
| 06/05/2007 | US7227007 Genetic engineering; libraries; lung cells; hybrids; process control; controlling activation; antiinflammatory agents; autoimmune diseases; infections; bone disorders; anticancer agents |
| 06/05/2007 | US7227004 Comprises monoclonal antibody for detection, diagnosis and treatment of cell proliferation disorders |
| 06/05/2007 | US7227003 Anti-TNF antibody fragments |
| 06/05/2007 | US7227002 Human antibodies that bind human 17-A1/EpCAM tumor antigen |
| 06/05/2007 | US7227001 Manganese superoxide dimutase exon 3-deleted isoforms and nucleic acid molecules encoding the isoforms |
| 06/05/2007 | US7227000 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins |
| 06/05/2007 | US7226998 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 06/05/2007 | US7226997 Mast cell-specific signal transducer and cDNA thereof |
| 06/05/2007 | US7226995 Use of C-reactive protein to treat immune complex-mediated renal disease |